ARCHIVES

Also in this 8-page issue: Dept. of Justice, Congress to investigate Merck and FDA actions on Vioxx; FDA asks IOM to study its monitoring system for approved drugs.

This article is from The Cancer Letter archive.

Vol. 30 No. 43 | November 12, 2004

Download PDF Visit The Full Archive

Related Articles

Arimidex Gets Full Approval For HR+ Early Breast Cancer

September 30, 2005

Also Unclear whether HHS Secretary Tommy Thompson will depart as previously planned.

November 5, 2004

NCI Sends Letter To Grantees To Explain Tighter Funding.

March 16, 2001

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

NCI To Fund More SPORE Grants In FY95 Recopetition

March 11, 1994

In Brief: Surgeons Oncology Group Gets NCI Funding To Conduct Multicenter Clinical Trials

April 17, 1998